The epidemic of prescription and non-prescription misuse of opioids has had devastating consequences, consuming millions of lives and becoming a leading cause of preventable deaths in the country. This epidemic has been fueled by an alarming increase in over prescribing, mishandling and overdosing from prescribed opioid painkillers.
Learn how your health plan can address the opioid crisis through a partnership of behavioral health and pharmacy.
Attendees will learn:
Who should attend this webinar: Payer audience – Commercial, Medicare, and Medicaid.
Martin Rosenzweig, M.D.
Senior Medical Director, Optum Behavioral Health
Dr. Rosenzweig has more than 20 years of experience in the field of behavioral health and expertise in the treatment of mood disorders. Before joining Optum in 2000, Dr. Rosenzweig spent three years as the Medical Director of the Counseling Program of PA Hospital in Philadelphia, two years as the Director of the Adult Treatment Service, and four years as the Director of the Mood Disorders Program at the Institute of Pennsylvania Hospital. Certified in Psychiatry by the American Board of Psychiatry and Neurology, he earned his MBBCh from the University of Witwatersrand Medical School in Johannesburg, South Africa. Dr. Rosenzweig has been awarded a fellowship by the National Psychiatric Endowment Fund, and the J. Martin Myers Award for outstanding contribution to the PA Hospital. In 1997, he was named “Top Doctor” by Philadelphia Magazine. He continues as a practicing psychiatrist today.
Dr. Rosenzweig has served as senior medical director for the Philadelphia Care Advocacy Center since 2001. In this role, he has overseen the clinical operation of many large national customers. Over the last 3 years, he has been architect of the Optum response to the growing opiate epidemic and helps to coordinate operational, network and affordability efforts to address the trend including development of specialty Medication Assisted Treatment (MAT) network. He also is a voting member of the UHC Pharmacy & Therapeutics Committee and represents behavioral perspective on medications.
David Calabrese, R.Ph, MHP
Vice President and Chief Pharmacy Officer, OptumRx
David Calabrese is Vice President and Chief Pharmacy Officer for OptumRx, the nation’s 3rd largest Pharmacy Benefit Manager (PBM), serving over 66 million lives across multiple lines of business. At OptumRx, David maintains executive level oversight and strategic accountability for several of the organization’s clinical programs and services, including but not limited to Clinical Account Management; Pharmacy & Therapeutics Committee activity; and overall Clinical Strategy. Mr. Calabrese comes to OptumRx through its acquisition of Catamaran, a large national PBM based in Chicago, where he also served as Chief Pharmacy Officer since 2011. Prior to that, he served as Chief Clinical Officer at MedMetrics Health Partners, a small regionally-based PBM in Massachusetts.
Mr. Calabrese’s career spans over 28 years in managed care clinical pharmacy leadership including roles at Harvard Pilgrim Health Care, a large, regionally-based non-profit health plan, and with CareGroup, an integrated healthcare system, both in Boston, MA.
Mr. Calabrese holds both a Bachelor’s degree in Pharmacy and a Master’s degree in Health Professions from Northeastern University, where he currently maintains academic appointment as Assistant Clinical Professor in NU’s Bouvé College of Pharmacy and Allied Health Sciences.
He is an active member of several professional organizations including the Academy of Managed Care Pharmacy where he has served in various leadership positions. He also maintains a role as Clinical Editor of the healthcare industry journals, FormularyWatch and Managed Healthcare Executive and serves as an editorial advisory board member for various other key industry publications.
Mr. Calabrese speaks at numerous forums and is published on a variety of topics pertaining to pharmacy management in managed health care.